$5.67
0.010.18%
Last update: Nov 12, 10:53 AM
Curanex Pharmaceuticals Inc
CURXNASDAQ
Curanex Pharmaceuticals fell 50.9% from $11.52 to $5.66, behind the S&P 500's +11.2%. Its worst day was Sep 9 (−21.5%), and its low came Jul 27 at $3.74.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.80 was reported on $0.00 revenue.
+2.4% · S&P 500 −0.9%
Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis.
Story events cover the past 12 months · Times ET
+45.8%, the year's best day, on 10M shares, the year's heaviest volume · S&P 500 −0.6%
EPS of $-2.40 was reported on $0.00 revenue.
+1.7% · S&P 500 −0.3%
Curanex Pharmaceuticals shares fell 18.5%, while the S&P 500 rose 0.0%.
−18.5% · S&P 500 0.0%
EPS of $-2.20 was reported on $0.00 revenue.
−0.7% · S&P 500 +0.8%
Curanex Pharmaceuticals shares fell 16.4%, while the S&P 500 rose 1.0%.
−16.4% · S&P 500 +1.0%
Curanex Pharmaceuticals closed at its lowest level of the year, 67.5% below where the year started.
−1.0% · S&P 500 0.0%
EPS of $-2.40 was reported on $0.00 revenue.
−0.9% · S&P 500 −0.2%
Curanex Pharmaceuticals shares fell 21.5%, while the S&P 500 fell 0.5%.
−21.5%, the year's worst day · S&P 500 −0.5%
Curanex Pharmaceuticals shares rose 15.9%, while the S&P 500 rose 0.3%.
+15.9% · S&P 500 +0.3%
Where it ended: a close of $5.66 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All CURX analyst actionsNothing in the past 12 months.
All CURX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CURX and SPY from Benzinga historical bars. Not investment advice.
